Cardiology

Research tackling sudden death heart condition

Over 50,000 people in Yorkshire and the Humber carry a faulty gene putting them at high risk of developing heart disease or sudden death, according to new estimates by the British Heart Foundation.

Medications

Duchenne muscular dystrophy drug approved by FDA

The powerful US Food and Drug Administration (FDA) has given the green light to a drug developed by WA researchers Sue Fletcher and Steve Wilton for treating Duchenne muscular dystrophy.

Genetics

Gene fault identified in people with schizophrenia

(Medical Xpress)—A large team of researchers from the U.S., Sweden, Finland and the U.K. has identified a gene fault that appears to be unique to people with schizophrenia and other neural diseases. In their paper published ...

Ophthalmology

Pioneering gene therapy takes aim at inherited blindness

Canada's first human gene therapy trial for eyes—the replacement of a faulty gene with a healthy one—is now underway at the Royal Alexandra Hospital to preserve and potentially restore vision for people with a genetic ...

page 4 from 8